Editorial: Insights into gastrointestinal cancer metastasis from preclinical models - Takeaways - MDSpire

Editorial: Insights into gastrointestinal cancer metastasis from preclinical models

  • By

  • Bruna Costa

  • Alyssa Schledwitz

  • Jean-Pierre Raufman

  • May 20, 2026

  • 0 min

Share

  • 1

    Mice have been the primary preclinical model for studying gastrointestinal cancer metastasis for over 40 years.

  • 2

    The metastatic spread of cancer cells is the leading cause of death in gastrointestinal cancer patients.

  • 3

    Recent studies emphasize the role of non-coding RNAs in regulating metastatic progression and tumor microenvironment interactions.

  • 4

    Emerging technologies like single-cell RNA sequencing are enhancing our understanding of tumor biology and metastasis.

  • 5

    Innovative preclinical models are crucial for linking mechanistic insights to potential therapeutic strategies in GI cancer.

Original Source(s)

Editorial: Insights into gastrointestinal cancer metastasis from preclinical models

  • by Bruna Costa, Alyssa Schledwitz, Jean-Pierre Raufman

  • May 20, 2026

Related Content

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Is full adherence mandatory? Real-world outcomes of completing perioperative chemoimmunotherapy in resectable non-small cell lung cancer

Molecular mechanisms of KMT2C alterations in gastrointestinal cancers: enhancer network destabilization, lineage plasticity, and clinical translation